128 related articles for article (PubMed ID: 34802106)
1. ASO Author Reflections: Adding Value to Multidisciplinary Care by Incorporating Structured Surgeon Survey Assessment of the Effect of Neoadjuvant Therapies on Melanoma Operations.
Hieken TJ; Piltin MA; Block MS
Ann Surg Oncol; 2022 Feb; 29(2):787-788. PubMed ID: 34802106
[No Abstract] [Full Text] [Related]
2. ASO Author Reflections: Neoadjuvant Treatment for Melanoma-Where Are We Now?
Sharon CE; Karakousis GC
Ann Surg Oncol; 2022 Dec; 29(13):8501-8502. PubMed ID: 35882694
[No Abstract] [Full Text] [Related]
3. ASO Author Reflections: The Landmark Series: Neoadjuvant Systemic Therapy (NAST) for Stage 3 Melanoma Patients: A Potential Paradigm Shift in Management.
van Akkooi ACJ; Spillane AJ
Ann Surg Oncol; 2020 Jul; 27(7):2201-2202. PubMed ID: 32382889
[No Abstract] [Full Text] [Related]
4. ASO Author Reflections: Tumor Immune Profiling-Based Neoadjuvant Immunotherapy for Locally Advanced Melanoma.
Mahuron KM; Levine LS; Daud AI
Ann Surg Oncol; 2020 Oct; 27(11):4131-4132. PubMed ID: 32488511
[No Abstract] [Full Text] [Related]
5. ASO Author Reflections: Frequent Relapses Prior to the Start of Adjuvant Therapy in Stage IIIB/C Melanoma.
Bloemendal M; van Willigen WW; Bol KF; de Wilt JHW
Ann Surg Oncol; 2019 Nov; 26(12):3953-3954. PubMed ID: 31396780
[No Abstract] [Full Text] [Related]
6. ASO Author Reflections: What Role Do Surgeons Play in the Era of Effective Systemic Therapy for Melanoma?
Nelson DW; Faries MB
Ann Surg Oncol; 2019 Dec; 26(13):4619-4620. PubMed ID: 31531796
[No Abstract] [Full Text] [Related]
7. ASO Author Reflections: Why the Surgeon, Who is the Person Most Influential in the Management of Breast Cancer, Must Have a Multidisciplinary Mindset.
Silva E; Tan M
Ann Surg Oncol; 2020 Dec; 27(Suppl 3):739-740. PubMed ID: 31811436
[No Abstract] [Full Text] [Related]
8. ASO Author Reflections: Surgeons Adding Value-Are Synoptic Operative Reports a Step Forward in Cancer Care?
Hieken TJ; Morris AM; Burns WR; Francescatti AB; Wong SL
Ann Surg Oncol; 2022 Oct; 29(11):6534-6535. PubMed ID: 35015181
[No Abstract] [Full Text] [Related]
9. ASO Author Reflections: Tailoring of Targeted Axillary Dissection-Intraoperative Nodal Evaluation Reduces Second Operations.
Wu S; Liu G
Ann Surg Oncol; 2018 Dec; 25(Suppl 3):634-635. PubMed ID: 30411270
[No Abstract] [Full Text] [Related]
10. ASO Author Reflections: Assessing the Impact of Neoadjuvant Therapy: A Real View Perspective.
Kamarajah SK; Phillips AW
Ann Surg Oncol; 2020 Sep; 27(9):3193-3194. PubMed ID: 32227268
[No Abstract] [Full Text] [Related]
11. ASO Author Reflections: Biomarker Changes After Neoadjuvant Therapy: Do They Matter?
Mohan SC; Chung A
Ann Surg Oncol; 2021 Oct; 28(11):5918-5919. PubMed ID: 33791901
[No Abstract] [Full Text] [Related]
12. ASO Author Reflections: Neoadjuvant Endocrine Therapy: A Pill in Time Saves Nine.
Williams AD; Bleicher RJ
Ann Surg Oncol; 2022 Mar; 29(3):1692-1693. PubMed ID: 34988829
[No Abstract] [Full Text] [Related]
13. ASO Author Reflections: Role of Contrast-Enhanced Spectral Mammography in the Assessment of Residual Breast Cancer After Neoadjuvant Systemic Therapy.
Hilal T; Patel BK
Ann Surg Oncol; 2018 Dec; 25(Suppl 3):652-653. PubMed ID: 30324476
[No Abstract] [Full Text] [Related]
14. ASO Author Reflections: Multimodality Therapy for Patients with Pancreatic Cancer: Neoadjuvant Therapy for All?
da Costa WL; Massarweh NN
Ann Surg Oncol; 2021 Jun; 28(6):3196-3197. PubMed ID: 33221979
[No Abstract] [Full Text] [Related]
15. ASO Author Reflections: Use of Machine Learning to Identify Patients with Intrahepatic Cholangiocarcinoma Who Could Benefit More from Neoadjuvant Therapies.
Tsilimigras DI; Mehta R; Pawlik TM
Ann Surg Oncol; 2020 Apr; 27(4):1120-1121. PubMed ID: 31712926
[No Abstract] [Full Text] [Related]
16. ASO Author Reflections: Impact of Neoadjuvant Chemotherapy on Exploration of Fertility Preservation.
Crown A; Gemignani ML
Ann Surg Oncol; 2020 Dec; 27(Suppl 3):699-700. PubMed ID: 32776189
[No Abstract] [Full Text] [Related]
17. ASO Author Reflections: Is Neoadjuvant Chemotherapy Associated with Acceptable Short-Term Outcomes for Pancreatic Cancer?
Kamarajah SK; Dahdaleh F
Ann Surg Oncol; 2021 Apr; 28(4):1906-1907. PubMed ID: 33389290
[No Abstract] [Full Text] [Related]
18. ASO Author Reflections: Nodal Downstaging and Conversion to Breast-Conserving Surgery Following Neoadjuvant Endocrine Therapy.
Montagna G; Morrow M; Pilewskie M
Ann Surg Oncol; 2020 Dec; 27(Suppl 3):693-694. PubMed ID: 32797378
[No Abstract] [Full Text] [Related]
19. ASO Author Reflections: Future Prospects of Neoadjuvant Chemotherapy for Gastric Cancer.
Kano M; Matsubara H
Ann Surg Oncol; 2020 Dec; 27(Suppl 3):721-722. PubMed ID: 31797227
[No Abstract] [Full Text] [Related]
20. ASO Author Reflections: Neoadjuvant Therapy for Pancreatic Cancer-Standard of Care or Still Worth Debating?
Chawla A; Wang J
Ann Surg Oncol; 2020 Apr; 27(4):1201-1202. PubMed ID: 31848817
[No Abstract] [Full Text] [Related]
[Next] [New Search]
